financetom
Business
financetom
/
Business
/
Riley Exploration Permian Insider Sold Shares Worth $418,782, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Riley Exploration Permian Insider Sold Shares Worth $418,782, According to a Recent SEC Filing
May 26, 2025 7:07 AM

03:43 PM EDT, 05/13/2025 (MT Newswires) -- Bobby Riley, Director, CEO, on May 12, 2025, sold 15,000 shares in Riley Exploration Permian ( REPX ) for $418,782. Following the Form 4 filing with the SEC, Riley has control over a total of 424,636 common shares of the company, with 424,636 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1001614/000175603025000011/xslF345X05/wk-form4_1747164970.xml

Price: 29.81, Change: +1.63, Percent Change: +5.78

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Anaergia's Italian Unit Expands Scope at Three Biomethane Facilities Being Built in Italy, Increasing Contracts by C$17 Million
Anaergia's Italian Unit Expands Scope at Three Biomethane Facilities Being Built in Italy, Increasing Contracts by C$17 Million
Mar 17, 2026
06:33 AM EDT, 03/17/2026 (MT Newswires) -- An Italian subsidiary of Anaergia ( ANRGF ) signed amendments to three previously announced contracts with an entity owned by QGM relating to the development of three state-of-the-art biomethane production facilities in Ostellato, Copparo, and Derovere, in northern Italy, the company said on Tuesday. The company further said that, as a result of...
Roche ramps up AI computing capacity with Nvidia chip expansion
Roche ramps up AI computing capacity with Nvidia chip expansion
Mar 17, 2026
BERLIN, March 16 (Reuters) - Swiss drugmaker Roche said on Monday it had expanded its artificial intelligence computing capacity with more than 2,100 Nvidia ( NVDA ) chips to support drug and diagnostics development. Roche said the additional hardware would speed up work across its research and development operations, including modelling, data analysis and clinical trial processes. The drugmaker said...
Nvidia bets on AI inference as chip revenue opportunity hits $1 trillion
Nvidia bets on AI inference as chip revenue opportunity hits $1 trillion
Mar 17, 2026
SAN JOSE, California, March 16 (Reuters) - Nvidia ( NVDA ) said the revenue opportunity for its artificial intelligence chips may reach at least $1 trillion through 2027, as the company outlined a strategy to compete more aggressively in the fast-growing market for running AI systems in real time. CEO Jensen Huang unveiled a new central processor and an AI...
Greenwich LifeSciences Says Breast Cancer Therapy Reduces Cancer Recurrence in Late-Stage Study
Greenwich LifeSciences Says Breast Cancer Therapy Reduces Cancer Recurrence in Late-Stage Study
Mar 17, 2026
06:37 AM EDT, 03/17/2026 (MT Newswires) -- Greenwich LifeSciences ( GLSI ) said Tuesday that preliminary data from its late-stage trial of its experimental therapy, GLSI-100, to prevent breast cancer recurrences, showed a continued reduction in recurrence rates among certain patients. The drug developer said six months of additional patient data demonstrated recurrence rate of less than 1% per year...
Copyright 2023-2026 - www.financetom.com All Rights Reserved